Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Incyte Corporation    INCY   US45337C1027

INCYTE CORPORATION (INCY)

17
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Latest news on INCYTE CORPORATION
4d ago INCYTE : Diagnostics lab makes yet another acquisition
08/21 INCYTE : Market Movers - Biotech Stocks -- Progenics Pharma, Rexahn Pharma, Immu..
08/14 INCYTE : Secures FDA sNDA for Jakafi (ruxolitinib)
08/08 INCYTE : Gets FDA sNDA for Jakafi (ruxolitinib)
08/07 INCYTE : Assigned Patent
08/06 INCYTE : Announces Clinical Trial Agreement to Evaluate Combination of Two Novel..
08/05 INCYTE : FDA Accepts Supplemental New Drug Application for Jakafi® (ruxolitinib)..
08/01 Incyte Reports 2014 Second-Quarter Financial Results and Updates Shareholders..
07/31 INCYTE : Management's Discussion and Analysis of Financial Condition and Results..
07/31 INCYTE : Results of Operations and Financial Condition, Financial Statements and..
07/31 INCYTE : Reports 2014 Second-Quarter Financial Results and Updates Shareholders ..
07/30 INCYTE : Announces Clinical Trial Agreement to Evaluate Combination of Two Novel..
07/29 INCYTE : Assigned Patent
07/28 INCYTE : Jakafi® (ruxolitinib) Product Label Expanded to Include Overall Surviva..
07/23 INCYTE : Announces Top-Line Results from RELIEF Trial of Ruxolitinib in Patients..
07/18 INCYTE : Gets $25 Million Milestone Payment for Approval of Jakavi (ruxolitinib)..
07/17 INCYTE : Leadership Appointments, Earnings Conference Calls, Milestone Payments,..
07/16 INCYTE : Achieves $25 Million Milestone for Approval of Jakavi® ruxolitinib in J..
07/14 INCYTE : to Report Second Quarter 2014 Financial Results on July 31
07/11 INCYTE : Earns $25 Million Milestone Payment for Approval of Jakavi (ruxolitinib..
07/08 INCYTE : Achieves $25 Million Milestone for Approval of Jakavi® (ruxolitinib) in..
07/03 INCYTE : Assigned Patent
07/02 INCYTE : Lab here acquires Yakima pathology services group
06/27 INCYTE : Assigned Patent
06/23 INCYTE : Assigned Patent
06/19 INCYTE : Patent Issued for Hydroxyl, Keto, and Glucuronide Derivatives of 3-(4-(..
06/18 INCYTE : to Present at the 9th Annual JMP Securities Healthcare Conference
06/13 INCYTE : Assigned Patent
06/13 GERON : GERN) Gains After FDA Green Lights Imetelstat Trial Resumption
06/12 INCYTE : to Present at the 9th Annual JMP Securities Healthcare Conference
06/11 INCYTE : Announces Preliminary Results of a Phase I/II Study of Combination Immu..
06/06 INCYTE : Assigned Patent
06/05 INCYTE : Releases Preliminary Study Results of Combination Immunotherapy for Mel..
06/05 INCYTE : Releases Full Results from RECAP Phase II Trial of Jakafi in Combinatio..
06/05 INCYTE : Releases Preliminary Trial Results
06/04 BRISTOL MYERS SQUIBB : and Incyte Enter Clinical Collaboration Agreement to Eval..
06/03 INCYTE : Pivotal Phase III Data in Polycythemia Vera Show that Jakafi® (ruxoliti..
06/02 INCYTE : Announces Full Results from Proof-of-Concept Phase II RECAP Trial of Ja..
06/02 INCYTE : Announces Preliminary Results of a Phase I/II Study of Combination Immu..
05/29 BRISTOL MYERS SQUIBB : and Incyte Enter Clinical Collaboration Agreement to Eval..
05/28 INCYTE : New Data for Multiple Incyte Cancer Programs to Be Presented at the 201..
05/27 INCYTE : Bristol-Myers Squibb and Incyte Enter Clinical Collaboration Agreement ..
05/23 NOVARTIS : presents key advances in cancer research at ASCO and EHA from four ne..
05/23 INCYTE : Assigned Patent
05/21 INCYTE : Patent Issued for Salts of the Janus Kinase Inhibitor ®-3-(4-(7H-Pyrrol..
05/21 INCYTE : and MedImmune Announce Collaboration on Immuno-Oncology Combination Cli..
05/20 INCYTE : to Present at Upcoming Investor Conferences
05/16 INCYTE : Assigned Patent
05/14 ASTRAZENECA : MedImmune and Incyte Announce Collaboration on immuno-ONCOLOGY Com..
05/14 INCYTE : and MedImmune Announce Collaboration on Immuno-Oncology Combination Cli..
05/12 INCYTE : Assigned Patent
05/09 INCYTE : Assigned Patent
05/07 INCYTE : Reports 2014 First-Quarter Financial Results and Updates Shareholders o..
05/06 INCYTE : Technical Data on Biotech Stocks -- Research on Exact Sciences, Amgen, ..
05/02 INCYTE : to Present at Upcoming Investor Conferences
05/02 INCYTE : Reports 2014 First-Quarter Financial Results and Updates Shareholders o..
05/02 INCYTE : 600th ABW-Abbo Cath G-20 (Incyte) And 44 L/I
05/01 INCYTE : Management's Discussion and Analysis of Financial Condition and Results..
05/01 INCYTE : Reports 2014 First-Quarter Financial Results and Updates Shareholders o..
04/28 INCYTE : Assigned Patent
04/18 INCYTE : Assigned Patent
04/16 INCYTE : to Report First Quarter 2014 Financial Results on May 1
04/14 INCYTE : Technical Data on Biotech Stocks -- Research on Alexion Pharma, Incyte,..
04/11DJRiding the Tech Roller Coaster
04/11DJRiding the Tech Roller Coaster -2-
04/11 INCYTE : Assigned Patent
03/28 As U.S. momentum stocks take beating, some sectors benefit
03/25 INCYTE : Pre-market Biotech Picks -- Research on Merrimack Pharma, Alexion Pharm..
03/24 MID CAP LOSERS : Incyte Corporation (NASDAQ:INCY), Tableau Software (NYSE:DATA),..
03/12 INCYTE CORPORATION : Incyte Reports Positive Top-Line Results from Phase III Stu..
03/10 INCYTE CORP : Change in Directors or Principal Officers (form 8-K)
03/07 INCYTE CORPORATION : Incyte Announces Positive Top-Line Results from Phase III S..
02/21 INCYTE CORPORATION : INCYTE CORP - 10-K - Management's Discussion and Analysis o..
02/21 INCYTE CORPORATION : Incyte to Present at Upcoming Investor Conferences
02/18 INCYTE CORPORATION : Incyte to Present at Upcoming Investor Conferences
1  2  3  4Next
Advertisement
Chart
Duration : Period :
Incyte Corporation Technical Analysis Chart | INCY | US45337C1027 | 4-Traders
Income Statement Evolution
Incyte Corporation : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF